Recently Viewed

News Announcement

Natco Pharma: Announcement under Regulation 30 (LODR)-Press Release / Media Release

03-Feb-2026 Follow Value Research Online on Google download pdfDownload PDF Natco Pharma

Natco Receives Tentative Approval for Erdafitinib Tables (generic of Balversa) from the United States Food and Drug Administration (U.S.FDA)

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.